Clínic Barcelona

University of Barcelona and Hospital Clínic collaborate to improve the efficacy of advanced lung cancer treatment

To advance in the fight against lung cancer,  University of Barcelona (UB) and  Hospital Clínic of Barcelona collaborate with Boehringer Ingelheim to look for new ways of nintedanib efficiency, an anti-angiogenic drug for the treatment of this disease. Lung cancer is the leading cause of cancer death worldwide and November is the international month of this disease.